The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.
Lifelong persistence of Epstein-Barr virus (EBV) in infected hosts is mainly owed to the virus' pronounced abilities to evade immune responses of its human host. Active immune evasion mechanisms reduce the immunogenicity of infected cells and are known to be of major importance during lytic inf...
Main Authors: | Simon Jochum, Andreas Moosmann, Stephan Lang, Wolfgang Hammerschmidt, Reinhard Zeidler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC3355093?pdf=render |
Similar Items
-
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.
by: Chiara Rancan, et al.
Published: (2015-06-01) -
EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL.
by: Romana Ruiss, et al.
Published: (2011-01-01) -
HLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11.
by: Cosima Zimmermann, et al.
Published: (2019-09-01) -
Sponsorer vil styre programproduksjonen
by: Svein Brurås
Published: (1998-01-01) -
Tonglin Vil eco station
by: Yen-Chen Ou, et al.
Published: (2011)